{"meta":{"query_hash":"1a7453412365","filters":{"venue":"Biologics"},"cohort_total":20,"direct_labels_cover":0,"predictions_cover":20,"exported":20,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1a7453412365","api":"https://metacan.xera.ac/api/v1/cohort?venue=Biologics"},"results":[{"id":"W1971365073","doi":"10.2147/btt.s6748","title":"Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib","year":2010,"lang":"en","type":"article","venue":"Biologics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Sunitinib; Sorafenib; Everolimus; Medicine; Internal medicine; Oncology; Renal cell carcinoma; Urology","score_opus":0.01719074779736497,"score_gpt":0.24529601222092892,"score_spread":0.22810526442356396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971365073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5085087,0.35163072,0.002371207,0.014692394,0.0037846605,0.0010750128,0.0046333475,0.0009628576,0.11234104],"genre_scores_gemma":[0.83274126,0.07301681,0.0030690131,0.0061560087,0.0024421762,0.00032604532,0.0050168945,0.00013085411,0.07710099],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976283,0.000040828763,0.000017361195,0.000022537466,0.00011542555,0.000041049156],"domain_scores_gemma":[0.9996964,0.000035130943,0.000087258275,0.000010663526,0.000051317827,0.00011930306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040721774,0.00022408282,0.0005140542,0.0002957842,0.00027780203,0.00065866293,0.00017457729,0.0005534695,0.010706549],"category_scores_gemma":[0.0004988829,0.00007906555,0.0005188539,0.00026185333,0.00011748126,0.00026028694,0.00018897704,0.00077652757,0.0024464699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010472389,0.00080596324,0.010114082,0.001660588,0.00038954456,0.0013375746,0.00010711358,0.0001842455,0.023333611,0.0008748322,0.11145302,0.839267],"study_design_scores_gemma":[0.011573186,0.011958547,0.10369256,0.00048818794,0.0007956543,0.010414144,0.000085334585,0.00060861686,0.019613536,0.00044508473,0.8402644,0.000060669434],"about_ca_topic_score_codex":0.00054648245,"about_ca_topic_score_gemma":0.0022072815,"teacher_disagreement_score":0.010706549,"about_ca_system_score_codex":0.00046680804,"about_ca_system_score_gemma":0.00060083123,"threshold_uncertainty_score":0.035816967},"labels":[],"label_agreement":null},{"id":"W1983465503","doi":"10.2147/btt.s55196","title":"Therapeutic vaccines and cancer: focus on DPX-0907","year":2014,"lang":"en","type":"review","venue":"Biologics","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Immunovaccine (Canada); Dalhousie University","funders":"","keywords":"Immune system; Immunogenicity; Antigen; Vaccination; Cancer vaccine; Medicine; Immunology; Cancer; Prostate cancer; Ovarian cancer; Immunotherapy; Internal medicine","score_opus":0.05137077056622755,"score_gpt":0.32996260898802704,"score_spread":0.27859183842179946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983465503","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77370316,0.15422162,0.03552137,0.005901597,0.00080457254,0.0006021044,0.0003878866,0.00029868732,0.028559018],"genre_scores_gemma":[0.85308963,0.08603317,0.038271014,0.0029643956,0.0006032154,0.0003211516,0.00080211833,0.000103729086,0.017811462],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998524,0.000043800363,0.000008919722,0.000028488068,0.000037709186,0.000028685503],"domain_scores_gemma":[0.99992454,0.00002039049,0.000017034698,0.000006977964,0.000012491148,0.000018483797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029962347,0.00033572872,0.00027080972,0.0002612842,0.00010448887,0.0004870679,0.00025403043,0.0004839976,0.0019231654],"category_scores_gemma":[0.00014935897,0.000113901035,0.0002564161,0.00017313888,0.0002570927,0.00047986984,0.00040512727,0.0008499682,0.0005757841],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037428117,0.0005905177,0.00087134016,0.0006994507,0.000022502962,0.0004513255,0.000087128814,0.0009672324,0.8579832,0.0056605744,0.0015976101,0.13069487],"study_design_scores_gemma":[0.0002380162,0.009975342,0.0049851243,0.00025942182,0.00010743127,0.00609365,0.00007315941,0.0033344894,0.81048554,0.0016431154,0.16276884,0.000035865603],"about_ca_topic_score_codex":0.00013323541,"about_ca_topic_score_gemma":0.00023157071,"teacher_disagreement_score":0.0019231654,"about_ca_system_score_codex":0.0002344566,"about_ca_system_score_gemma":0.00032476327,"threshold_uncertainty_score":0.0064336658},"labels":[],"label_agreement":null},{"id":"W2022859954","doi":"10.2147/btt.s1834","title":"Sunitinib for advanced renal cell cancer","year":2008,"lang":"en","type":"article","venue":"Biologics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Sunitinib; Medicine; Oncology; Tyrosine-kinase inhibitor; Internal medicine; Cancer; Kidney cancer; Pharmacology","score_opus":0.09144051966007616,"score_gpt":0.31365842360725577,"score_spread":0.2222179039471796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022859954","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.087869756,0.85512835,0.0017040469,0.009727942,0.0014038847,0.00010206269,0.00022082363,0.00028635928,0.043556806],"genre_scores_gemma":[0.6962696,0.2714918,0.002417048,0.0035021345,0.002195333,0.00006949076,0.000479052,0.000031518684,0.02354406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989367,0.000028781444,0.0000097928605,0.000011100469,0.000039737904,0.000016978833],"domain_scores_gemma":[0.9999167,0.00002056372,0.000019236571,0.0000032717903,0.0000112045955,0.00002906367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023304339,0.00017277604,0.0005638661,0.00033704037,0.0002465291,0.00023581115,0.000102995305,0.00032598732,0.0029595206],"category_scores_gemma":[0.00024825684,0.000034098586,0.00023482977,0.00023322835,0.000106309686,0.0002237357,0.00016083801,0.00043815398,0.00085783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010644,0.00013232777,0.0028259149,0.0011527879,0.000095337025,0.0014373581,0.000054992866,0.00021447026,0.0065333215,0.0010283941,0.04486188,0.9405988],"study_design_scores_gemma":[0.0015606205,0.0033752618,0.04187099,0.00058876164,0.00026627613,0.02497229,0.00009277244,0.0009968891,0.009063825,0.003235729,0.9139411,0.000035573743],"about_ca_topic_score_codex":0.00040095148,"about_ca_topic_score_gemma":0.0013744123,"teacher_disagreement_score":0.0029595206,"about_ca_system_score_codex":0.00034900862,"about_ca_system_score_gemma":0.00041398764,"threshold_uncertainty_score":0.00990057},"labels":[],"label_agreement":null},{"id":"W2024124694","doi":"10.2147/btt.s2372","title":"Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells","year":2008,"lang":"en","type":"article","venue":"Biologics","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Medicine; Gastrointestinal tract; Disease; Cell; Immunology; Internal medicine; Biology","score_opus":0.025908596585883903,"score_gpt":0.24696553339602761,"score_spread":0.2210569368101437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024124694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8461935,0.07276716,0.07013068,0.00057513657,0.00051412964,0.00030244706,0.00028504943,0.0004058251,0.008825997],"genre_scores_gemma":[0.9083861,0.03648569,0.045179937,0.00020029319,0.00008225404,0.00016925593,0.00020163824,0.000051187963,0.009243565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999081,0.000012266717,0.0000062529352,0.000020889964,0.000036047008,0.000016539983],"domain_scores_gemma":[0.9999517,0.00001318886,0.00001477619,0.0000050938343,0.0000071991903,0.000008073636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014811827,0.00029275843,0.00037402663,0.00021778683,0.00011381147,0.00029789595,0.00014278555,0.00034991716,0.00055729336],"category_scores_gemma":[0.0001137672,0.0001234546,0.00024968633,0.0001373236,0.00025015385,0.0002744908,0.00022752034,0.00041621088,0.0002796185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054216776,0.00003069076,0.00008844811,0.00021015333,0.000008078573,0.00009678311,0.000024457026,0.0003779956,0.9861994,0.00045109805,0.00009213187,0.012366597],"study_design_scores_gemma":[0.000017300104,0.00054106105,0.0007584358,0.000023640352,0.000029750725,0.0004046733,0.000020490688,0.0013323379,0.9813843,0.00008484169,0.015392293,0.000010879857],"about_ca_topic_score_codex":0.0005190354,"about_ca_topic_score_gemma":0.00075624906,"teacher_disagreement_score":0.00055729336,"about_ca_system_score_codex":0.00028435985,"about_ca_system_score_gemma":0.00018677721,"threshold_uncertainty_score":0.0020631552},"labels":[],"label_agreement":null},{"id":"W2024383628","doi":"10.2147/btt.2009.3580","title":"A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase","year":2009,"lang":"en","type":"review","venue":"Biologics","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Center for Research Resources; BioMarin Pharmaceutical","keywords":"Enzyme replacement therapy; Mucopolysaccharidosis; Medicine; SciELO; Intensive care medicine; Quality of life (healthcare); MEDLINE; Placebo; Pediatrics; Physical therapy; Internal medicine; Pathology; Alternative medicine; Biology; Disease","score_opus":0.06078147016024177,"score_gpt":0.379615220554129,"score_spread":0.3188337503938872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024383628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046772996,0.9985676,0.00008043143,0.00020204924,0.00009708111,0.00014720422,0.00022210796,0.0000056283225,0.00021007392],"genre_scores_gemma":[0.004029045,0.9949214,0.00034015207,0.00024902474,0.000051927374,0.00020867962,0.00012746516,0.0000029472017,0.000069432055],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937348,0.002129701,0.0025208278,0.00038478998,0.0010554503,0.0001743676],"domain_scores_gemma":[0.982634,0.011766135,0.0034069892,0.00021504902,0.0017163281,0.00026147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006448945,0.0014513811,0.008573845,0.013099715,0.0005865177,0.0025741877,0.0016816565,0.0015926363,0.0052345246],"category_scores_gemma":[0.02261385,0.00071513123,0.0057416325,0.013490451,0.00081184227,0.0020273179,0.0012972443,0.0010391304,0.00037896165],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014679269,0.0000121573785,0.00021670858,0.955306,0.0032637916,0.00007217466,0.00011481613,0.00006250677,0.00014429558,0.00018647377,0.0014066453,0.039067604],"study_design_scores_gemma":[0.00018047655,0.00020326852,0.0021336402,0.9313105,0.038850155,0.0003218358,0.00020859296,0.00006163826,0.00013357984,0.00024152227,0.026330614,0.000024161869],"about_ca_topic_score_codex":0.006805311,"about_ca_topic_score_gemma":0.01906155,"teacher_disagreement_score":0.013099715,"about_ca_system_score_codex":0.0033347416,"about_ca_system_score_gemma":0.010859527,"threshold_uncertainty_score":0.03410566},"labels":[],"label_agreement":null},{"id":"W2035860257","doi":"10.2147/btt.s61600","title":"Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia","year":2015,"lang":"en","type":"review","venue":"Biologics","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Obinutuzumab; Chemoimmunotherapy; Rituximab; Medicine; Chronic lymphocytic leukemia; CD20; Monoclonal antibody; Oncology; Immunology; Monoclonal antibody therapy; Lymphoma; Ofatumumab; Leukemia; Antibody","score_opus":0.0957161881886593,"score_gpt":0.4039952895686591,"score_spread":0.3082791013799998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035860257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010077,0.9994435,0.000019701161,0.00008423897,0.00004004296,0.0000019314496,0.0000058486644,0.000001443074,0.00030259538],"genre_scores_gemma":[0.00094435364,0.99857044,0.000059867118,0.00015450826,0.000070271126,0.0000036234153,0.00001767498,6.7394234e-7,0.00017853192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979,0.000051677238,0.000042677348,0.00002836065,0.000072088355,0.000015131956],"domain_scores_gemma":[0.99974114,0.00013085459,0.00004710082,0.000004883222,0.000057414287,0.00001859374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005603394,0.00041816657,0.001065567,0.0016155221,0.00017636585,0.0006375992,0.0006809089,0.0006857661,0.0018690936],"category_scores_gemma":[0.0007715505,0.00018686842,0.00048744454,0.0012732605,0.00027150722,0.000656431,0.00040869674,0.0010865963,0.00077258167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014110727,0.00004450842,0.00023456023,0.018361432,0.0001404462,0.00019084767,0.00005711371,0.00019308407,0.0008342974,0.0010711907,0.014181886,0.9645495],"study_design_scores_gemma":[0.00009105905,0.00022172397,0.0019360894,0.009380862,0.0003696783,0.0022129,0.00006926628,0.0001093649,0.00058958336,0.0011266432,0.9838718,0.000021078233],"about_ca_topic_score_codex":0.0008503355,"about_ca_topic_score_gemma":0.002144048,"teacher_disagreement_score":0.0018690936,"about_ca_system_score_codex":0.0005019012,"about_ca_system_score_gemma":0.0007294074,"threshold_uncertainty_score":0.006252706},"labels":[],"label_agreement":null},{"id":"W2043209924","doi":"10.2147/btt.s24220","title":"Role of vandetanib in the management of medullary thyroid cancer","year":2012,"lang":"en","type":"article","venue":"Biologics","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre hospitalier de l'Université Laval; Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Vandetanib; Medullary thyroid cancer; Medullary cavity; Medicine; Thyroid cancer; Cancer; Internal medicine; Oncology; Receptor","score_opus":0.02566177312025661,"score_gpt":0.2995599205318564,"score_spread":0.2738981474115998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043209924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004997656,0.98508203,0.0006107562,0.0037820216,0.00041349602,0.000022003049,0.00004270327,0.000041627773,0.0050077657],"genre_scores_gemma":[0.08571513,0.9025809,0.0020145716,0.0036393662,0.001931106,0.000046802903,0.0002629137,0.000027145732,0.0037819643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977154,0.000057939633,0.00002872501,0.000022812508,0.00008763361,0.00003141387],"domain_scores_gemma":[0.9996636,0.00011875973,0.000062147155,0.000007819536,0.00009269256,0.000054947493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007315933,0.00028495202,0.00072375004,0.0006524076,0.0001965678,0.0007029662,0.0005467088,0.00050629437,0.0014971608],"category_scores_gemma":[0.0008124847,0.00008788743,0.00041556783,0.00040502183,0.0003161161,0.00054532365,0.0003017854,0.0015358903,0.0005985898],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059621385,0.000110019115,0.0016350308,0.0025358088,0.00018216559,0.00082943734,0.00009773869,0.0011606435,0.008524327,0.0023797683,0.02534641,0.9566024],"study_design_scores_gemma":[0.00080654677,0.0020711918,0.010938339,0.002937506,0.0004072122,0.011560523,0.00018106063,0.001690692,0.006673343,0.0036883552,0.958963,0.00008223042],"about_ca_topic_score_codex":0.0015948829,"about_ca_topic_score_gemma":0.004515062,"teacher_disagreement_score":0.0015948829,"about_ca_system_score_codex":0.0011005779,"about_ca_system_score_gemma":0.0007449836,"threshold_uncertainty_score":0.0079853535},"labels":[],"label_agreement":null},{"id":"W2080246280","doi":"10.2147/btt.s24734","title":"B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms","year":2012,"lang":"en","type":"article","venue":"Biologics","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"University of Alberta; Ministry of Agriculture - Saskatchewan","keywords":"Pathogenesis; Antibody; Immunology; Autoantibody; Antigen; Antigen presentation; B cell; Biology; Medicine; T cell; Immune system","score_opus":0.018031149985900375,"score_gpt":0.2594838414677435,"score_spread":0.24145269148184312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080246280","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3820262,0.5737734,0.016331654,0.002941992,0.0010322926,0.00013047385,0.00012552933,0.00025485535,0.023383604],"genre_scores_gemma":[0.79887193,0.18573259,0.0055171405,0.0010535865,0.001373917,0.000047883717,0.00009633017,0.000017923305,0.0072886706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998097,0.00005722416,0.000015909362,0.000027259546,0.000056816378,0.000033112516],"domain_scores_gemma":[0.9998116,0.000053759173,0.000042657353,0.000006556513,0.000056359124,0.000029125653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047815277,0.0004268808,0.00038482476,0.000661741,0.00014628127,0.00049810763,0.00027918618,0.00058968185,0.0021216443],"category_scores_gemma":[0.00028618044,0.0000886408,0.00024346093,0.0002613201,0.00042876825,0.00034176357,0.00034106168,0.00062256213,0.0005871318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013595044,0.00041675643,0.019233746,0.0031972483,0.0002967585,0.004217159,0.00042884803,0.0006988875,0.6693411,0.010978232,0.0040387628,0.2857931],"study_design_scores_gemma":[0.0009148508,0.007643595,0.11040734,0.0021275543,0.0014426911,0.038214162,0.001348023,0.005498425,0.48894504,0.03574151,0.30761674,0.000100059064],"about_ca_topic_score_codex":0.00017911762,"about_ca_topic_score_gemma":0.00014682375,"teacher_disagreement_score":0.0021216443,"about_ca_system_score_codex":0.00016762094,"about_ca_system_score_gemma":0.00019606839,"threshold_uncertainty_score":0.0070976615},"labels":[],"label_agreement":null},{"id":"W2163182875","doi":"10.2147/btt.s19099","title":"Gut microbiota: next frontier in understanding human health and development of biotherapeutics","year":2011,"lang":"en","type":"article","venue":"Biologics","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":254,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds Québécois de la Recherche sur la Nature et les Technologies","keywords":"Gut flora; Dysbiosis; Human health; Disease; Biology; Microbiome; Immunology; Medicine; Computational biology; Biotechnology; Bioinformatics; Environmental health; Pathology","score_opus":0.2195514684969642,"score_gpt":0.31744924995802803,"score_spread":0.09789778146106384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163182875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023189206,0.9470549,0.008610434,0.033606682,0.0022881303,0.000018966219,0.00009644976,0.000112611706,0.005892877],"genre_scores_gemma":[0.03213877,0.9471204,0.0080632875,0.0068010255,0.0023725294,0.00005055129,0.00008187127,0.00003080173,0.003340757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915457,0.00034906206,0.00004366631,0.00010233872,0.00024319439,0.000107058964],"domain_scores_gemma":[0.9989792,0.00039958017,0.000121228804,0.00008372261,0.00023524923,0.00018106708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018172874,0.0006350094,0.0015613337,0.00094798795,0.0005134384,0.00265604,0.0007285356,0.0019936354,0.0034769897],"category_scores_gemma":[0.0017257179,0.00024083821,0.0005360203,0.0007570577,0.0022685304,0.0034711163,0.0015510389,0.004483819,0.0014500562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028391677,0.00017104787,0.0023216067,0.008282583,0.0001715566,0.00054801,0.0006621098,0.0011756772,0.028329322,0.15724756,0.05409722,0.7467094],"study_design_scores_gemma":[0.000022612812,0.00027545,0.0021883964,0.0028828299,0.000101209436,0.0008411171,0.0006563484,0.0008296475,0.0053461804,0.08586543,0.9009374,0.000053506585],"about_ca_topic_score_codex":0.0010672596,"about_ca_topic_score_gemma":0.0011712009,"teacher_disagreement_score":0.0034769897,"about_ca_system_score_codex":0.0013107599,"about_ca_system_score_gemma":0.003080381,"threshold_uncertainty_score":0.011631668},"labels":[],"label_agreement":null},{"id":"W2168849655","doi":"10.2147/btt.s1832","title":"Erlotinib in the treatment of advanced pancreatic cancer","year":2008,"lang":"en","type":"article","venue":"Biologics","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Gemcitabine; Pancreatic cancer; Medicine; Oncology; Internal medicine; Erlotinib Hydrochloride; Malignancy; Epidermal growth factor receptor; Clinical trial; Cancer; Chemotherapy; EGFR inhibitors; Targeted therapy; Tyrosine-kinase inhibitor; Cabozantinib; Pharmacology","score_opus":0.11071018200816875,"score_gpt":0.39854782635781943,"score_spread":0.2878376443496507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168849655","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16478929,0.7901429,0.001087104,0.010809142,0.00088554516,0.00007047185,0.000219995,0.00015674112,0.031838834],"genre_scores_gemma":[0.6140482,0.37110966,0.0014345609,0.0020213404,0.0011312037,0.000053355674,0.00036752343,0.0000149112675,0.009819144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998927,0.000034729073,0.000012099974,0.000010454982,0.000029113076,0.00002079844],"domain_scores_gemma":[0.9998939,0.000030424446,0.000027247705,0.0000050128215,0.000016575372,0.000026776628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004581487,0.00021123783,0.00047194818,0.00042957053,0.00015278699,0.00036283056,0.00018139907,0.00040999227,0.0009889266],"category_scores_gemma":[0.00034719665,0.000057594283,0.00019225666,0.0004570181,0.00014198627,0.00023563135,0.00017185595,0.00082880544,0.000401279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023254254,0.00043588856,0.002156356,0.000998505,0.000085816,0.0020926022,0.00008065973,0.0011855145,0.009261051,0.0017986655,0.014556637,0.96502286],"study_design_scores_gemma":[0.005679546,0.013048649,0.0545171,0.0012577457,0.00060110766,0.027556539,0.00020099457,0.0039295037,0.02193582,0.0038822903,0.8673077,0.00008299349],"about_ca_topic_score_codex":0.00070368004,"about_ca_topic_score_gemma":0.0018951107,"teacher_disagreement_score":0.0009889266,"about_ca_system_score_codex":0.0004838675,"about_ca_system_score_gemma":0.000335977,"threshold_uncertainty_score":0.0035107136},"labels":[],"label_agreement":null},{"id":"W2294831438","doi":"10.2147/btt.s71679","title":"Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumab","year":2016,"lang":"en","type":"review","venue":"Biologics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Vedolizumab; Ulcerative colitis; Medicine; Crohn's disease; Dermatology; Gastroenterology; Disease; Internal medicine","score_opus":0.06380168037548088,"score_gpt":0.37830337628042615,"score_spread":0.31450169590494526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294831438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020206372,0.99814785,0.000075854005,0.00020807509,0.00013678655,0.0000048848033,0.00001778255,0.000006025263,0.0012007663],"genre_scores_gemma":[0.0011392278,0.9974885,0.00015503005,0.00021338358,0.00012783536,0.000007772741,0.00003220256,0.0000016499857,0.0008345307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998493,0.000026945962,0.000026400245,0.000023306578,0.000059793972,0.000014181646],"domain_scores_gemma":[0.9998228,0.000086572494,0.000027569376,0.0000049836663,0.000041504754,0.000016608656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040982233,0.000529897,0.00091919623,0.0014657248,0.00019703279,0.0007190176,0.0005628027,0.0007176091,0.0032173083],"category_scores_gemma":[0.000566211,0.00016302265,0.0004437006,0.0010400728,0.00026202438,0.00077886344,0.00041224126,0.0015492286,0.0014571026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100679004,0.00006068841,0.00015516153,0.010255215,0.000078716905,0.00018988467,0.000051969033,0.00019687794,0.0017082295,0.002803768,0.02475125,0.9596476],"study_design_scores_gemma":[0.00003350826,0.00012155376,0.0006870477,0.0026547937,0.00010711625,0.0019360543,0.000039931067,0.00007257498,0.0005054275,0.001066127,0.9927651,0.000010799772],"about_ca_topic_score_codex":0.0004937142,"about_ca_topic_score_gemma":0.0013179064,"teacher_disagreement_score":0.0032173083,"about_ca_system_score_codex":0.0003992443,"about_ca_system_score_gemma":0.0005750522,"threshold_uncertainty_score":0.0107629895},"labels":[],"label_agreement":null},{"id":"W3119939393","doi":"10.2147/btt.s285610","title":"Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab","year":2021,"lang":"en","type":"article","venue":"Biologics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Discontinuation; Medicine; Biosimilar; Infliximab; Psoriatic arthritis; Rheumatoid arthritis; Internal medicine; Population; Disease","score_opus":0.0265783013926262,"score_gpt":0.2985141961853323,"score_spread":0.27193589479270613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119939393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990916,0.00025324075,0.00002909849,0.000029916484,0.000002321502,0.000003988187,0.0004139484,0.000001701628,0.00017429733],"genre_scores_gemma":[0.99887365,0.00010906636,0.00003575611,0.000026790742,0.0000051655898,0.0000053712556,0.0008410664,0.0000012592321,0.00010185744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990276,0.00021848833,0.00014531854,0.0002903948,0.00017031572,0.00014797004],"domain_scores_gemma":[0.99751437,0.00046375868,0.0014617586,0.00014833109,0.000171016,0.00024070729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096129486,0.0001780425,0.00039220252,0.00083016406,0.000248068,0.00057901983,0.00031040417,0.0004743433,0.0014588049],"category_scores_gemma":[0.0029859843,0.00014105004,0.00070726586,0.00082988845,0.0001945629,0.00038020773,0.0003729716,0.00047466625,0.00020732568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038184505,0.000022725668,0.9974819,0.000009963887,0.000070431626,0.000037798225,0.000059902206,0.00003619122,0.00011538053,0.000009929179,0.00009051953,0.0016833853],"study_design_scores_gemma":[0.00003115725,0.00018967532,0.99875665,0.0000115432,0.00004920411,0.0002517472,0.00015288997,0.00029068478,0.000054978485,0.00001679481,0.00019021949,0.000004455141],"about_ca_topic_score_codex":0.004490897,"about_ca_topic_score_gemma":0.005267874,"teacher_disagreement_score":0.004490897,"about_ca_system_score_codex":0.0003831685,"about_ca_system_score_gemma":0.0002801004,"threshold_uncertainty_score":0.008929551},"labels":[],"label_agreement":null},{"id":"W3158426855","doi":"10.2147/btt.s292692","title":"Baculoviruses in Gene Therapy and Personalized Medicine","year":2021,"lang":"en","type":"review","venue":"Biologics","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Genetic enhancement; Biosafety; Gene delivery; Tropism; Personalized medicine; Regenerative medicine; Biology; Gene; Computational biology; Vector (molecular biology); Virology; Virus; Medicine; Bioinformatics; Recombinant DNA; Stem cell; Biotechnology; Genetics","score_opus":0.10940486840089599,"score_gpt":0.37917405141318195,"score_spread":0.269769183012286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158426855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013751864,0.9958442,0.00050051574,0.0002895382,0.0003799688,0.000008725653,0.000016742417,0.000013476538,0.0028092861],"genre_scores_gemma":[0.00097901,0.9966395,0.000546189,0.00028189694,0.00021812471,0.000013001943,0.000038144197,0.0000031404866,0.0012810479],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999721,0.00005841004,0.000031169257,0.000040379582,0.00012445191,0.000024524363],"domain_scores_gemma":[0.99977666,0.000117362884,0.000023982966,0.000010591438,0.000052041134,0.000019322271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006263034,0.000751165,0.0009647158,0.0021396463,0.00032688142,0.0012859305,0.00065887923,0.0011644607,0.0034305232],"category_scores_gemma":[0.0005029682,0.00024713294,0.00046223638,0.0020106044,0.0006852634,0.0015170744,0.0007039768,0.0020051263,0.0021883629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053238007,0.00006662169,0.00014459921,0.0122047365,0.000054580614,0.00029770393,0.00012970866,0.00051976374,0.0067728874,0.017955655,0.030573597,0.93122685],"study_design_scores_gemma":[0.000005370524,0.000040098526,0.00017411345,0.0011612519,0.000025655492,0.0006142937,0.000025146677,0.00005624947,0.0008281754,0.0025347557,0.9945251,0.0000097887505],"about_ca_topic_score_codex":0.00074684987,"about_ca_topic_score_gemma":0.0007769572,"teacher_disagreement_score":0.0034305232,"about_ca_system_score_codex":0.00082472374,"about_ca_system_score_gemma":0.0009855349,"threshold_uncertainty_score":0.011476219},"labels":[],"label_agreement":null},{"id":"W3197380371","doi":"10.2147/btt.s259124","title":"Stem Cell Therapy for Burns: Story so Far","year":2021,"lang":"en","type":"review","venue":"Biologics","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Sunnybrook Hospital","funders":"","keywords":"Stem cell; Mesenchymal stem cell; Wound healing; Adult stem cell; Medicine; Stem cell transplantation for articular cartilage repair; Clinical uses of mesenchymal stem cells; Stem-cell therapy; Cell biology; Microvesicles; Exosome; Embryonic stem cell; Cancer research; Immunology; Biology; microRNA","score_opus":0.288923167243716,"score_gpt":0.4361278721146202,"score_spread":0.1472047048709042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197380371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008575668,0.9960653,0.000106675434,0.0015159281,0.0010184505,0.000003418367,0.000014684312,0.000007837266,0.0011819461],"genre_scores_gemma":[0.000582687,0.995624,0.00017373728,0.0012905598,0.0008276934,0.0000069533617,0.000024290204,0.0000030580131,0.0014670313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997619,0.000045172597,0.000027878003,0.000041420062,0.000103124075,0.000020533418],"domain_scores_gemma":[0.9992519,0.00042131374,0.00005234853,0.000022259352,0.00019143347,0.000060744238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084801775,0.0007592559,0.0008350891,0.0011380045,0.00045367976,0.0015048627,0.00066253636,0.0019738344,0.0045551234],"category_scores_gemma":[0.0013813351,0.00019865888,0.0005399702,0.0014985986,0.0007755824,0.0026016652,0.0008281213,0.0032440217,0.0032932048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091656606,0.000080558566,0.00012381816,0.010475083,0.00004598659,0.00014285865,0.000101437196,0.00019398596,0.0011487382,0.008037784,0.08248572,0.89707243],"study_design_scores_gemma":[0.0000097062175,0.000077220866,0.00022192374,0.0024448363,0.000037756312,0.0005035572,0.00006217393,0.00004273119,0.0002799539,0.0024381634,0.99387133,0.000010525575],"about_ca_topic_score_codex":0.0007357337,"about_ca_topic_score_gemma":0.0012858699,"teacher_disagreement_score":0.0045551234,"about_ca_system_score_codex":0.00046979598,"about_ca_system_score_gemma":0.00092972815,"threshold_uncertainty_score":0.015238464},"labels":[],"label_agreement":null},{"id":"W4240113361","doi":"10.2147/btt.s3766","title":"A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase","year":2009,"lang":"en","type":"review","venue":"Biologics","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Enzyme replacement therapy; Mucopolysaccharidosis; Medicine; SciELO; Quality of life (healthcare); MEDLINE; Intensive care medicine; Pediatrics; Physical therapy; Internal medicine; Disease; Biology","score_opus":0.06078147016024177,"score_gpt":0.379615220554129,"score_spread":0.3188337503938872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240113361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005397021,0.99831724,0.00009571119,0.00022826393,0.00010700434,0.00020130376,0.00027593746,0.0000066207267,0.00022819538],"genre_scores_gemma":[0.0044606165,0.9943007,0.00040101848,0.00027208225,0.000056932306,0.00027576718,0.0001517843,0.0000034682657,0.00007753293],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9929254,0.0024068514,0.0028435118,0.00044121087,0.0011849735,0.0001981058],"domain_scores_gemma":[0.9810451,0.012601698,0.003871191,0.0002317904,0.0019609807,0.00028915418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006979714,0.0015600147,0.008937667,0.014218675,0.0006254608,0.0027587938,0.0017811753,0.0016587314,0.0053314543],"category_scores_gemma":[0.024686113,0.00076948834,0.006228956,0.014514714,0.0008542796,0.0022848088,0.0013772846,0.0011075817,0.00037448865],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001320465,0.00001139443,0.00022665621,0.9605828,0.0030085645,0.000069366026,0.000120250326,0.0000599926,0.0001354835,0.000174601,0.0012578012,0.034221034],"study_design_scores_gemma":[0.00016469705,0.00019412738,0.0021777987,0.938252,0.035078164,0.00031758816,0.00022176238,0.000065710316,0.00012415412,0.00023253556,0.023146389,0.000025136316],"about_ca_topic_score_codex":0.00708698,"about_ca_topic_score_gemma":0.019799253,"teacher_disagreement_score":0.014218675,"about_ca_system_score_codex":0.0036680573,"about_ca_system_score_gemma":0.012492151,"threshold_uncertainty_score":0.03691274},"labels":[],"label_agreement":null},{"id":"W4322383175","doi":"10.2147/btt.s4964","title":"Potentials and limitations of microorganisms as renal failure biotherapeutics","year":2009,"lang":"en","type":"article","venue":"Biologics","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Dialysis; Medicine; Transplantation; Artificial kidney; Uremia; Pharmacology; Chemistry; Intensive care medicine; Internal medicine","score_opus":0.020207635790364383,"score_gpt":0.247989531296974,"score_spread":0.2277818955066096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322383175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053072315,0.90538496,0.01297369,0.010663697,0.0005994987,0.00007387788,0.00011656633,0.00008072912,0.017034704],"genre_scores_gemma":[0.31946847,0.6470737,0.017324405,0.00373044,0.0007451021,0.00020546567,0.00015025855,0.00004340022,0.01125865],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9990151,0.00036086314,0.000052776242,0.000091241265,0.00037609955,0.000103973085],"domain_scores_gemma":[0.9988285,0.0005574259,0.00017596998,0.00006895639,0.00026847294,0.000100690035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016677856,0.00042402034,0.00051771465,0.00070838624,0.00024945292,0.0017462615,0.00054442673,0.0011802583,0.0024991254],"category_scores_gemma":[0.0010533566,0.00018682993,0.00054581143,0.00041817976,0.0008544425,0.0014267177,0.000905227,0.0011469864,0.0009023718],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009314382,0.00040633485,0.0032689495,0.0053050625,0.00014385166,0.0008266897,0.0004896989,0.0018223348,0.24151331,0.03254693,0.007633631,0.70511174],"study_design_scores_gemma":[0.00008601084,0.0040446967,0.0037819569,0.0019341923,0.00023068393,0.0040397528,0.0006818077,0.002280328,0.24205258,0.0109781595,0.72977465,0.00011507986],"about_ca_topic_score_codex":0.00051870575,"about_ca_topic_score_gemma":0.00093513675,"teacher_disagreement_score":0.0024991254,"about_ca_system_score_codex":0.0006708557,"about_ca_system_score_gemma":0.00085902296,"threshold_uncertainty_score":0.008820176},"labels":[],"label_agreement":null},{"id":"W4393062477","doi":"10.2147/btt.s369783","title":"Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy","year":2024,"lang":"en","type":"article","venue":"Biologics","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Endometrial cancer; Medicine; Identification (biology); Precision medicine; Personalized medicine; Cancer; Translational research; Targeted therapy; Biomarker; Computational biology; Bioinformatics; Biology; Internal medicine; Pathology","score_opus":0.06881452045671953,"score_gpt":0.3414309784189212,"score_spread":0.2726164579622017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393062477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005391766,0.9668044,0.0027948676,0.018464593,0.0008498085,0.000056610614,0.00014090764,0.00008102131,0.005415956],"genre_scores_gemma":[0.06882317,0.908723,0.0075907526,0.007557666,0.0018871016,0.00017037465,0.0003316083,0.000030807012,0.0048854765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963343,0.00013391708,0.000028645323,0.000047492107,0.00008355116,0.00007300992],"domain_scores_gemma":[0.99965453,0.000111543326,0.000059322076,0.000024098126,0.00008610124,0.00006426565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014164156,0.0005357118,0.0010547885,0.0009245362,0.000428842,0.0019396159,0.0007640928,0.0012165646,0.004682038],"category_scores_gemma":[0.0009803169,0.00022033244,0.00076226995,0.00057922734,0.0008987606,0.0016736838,0.00096006744,0.003098081,0.0013868245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009972701,0.0007041233,0.0026054815,0.0063347593,0.00030838867,0.0013367961,0.00036247753,0.0020494333,0.034271426,0.038911536,0.046997055,0.8651212],"study_design_scores_gemma":[0.0005468084,0.002623219,0.005346199,0.0041356077,0.00043121728,0.0032829992,0.0006670721,0.002626542,0.010557381,0.037491776,0.9322022,0.00008888672],"about_ca_topic_score_codex":0.00046812434,"about_ca_topic_score_gemma":0.002175784,"teacher_disagreement_score":0.004682038,"about_ca_system_score_codex":0.0008625564,"about_ca_system_score_gemma":0.0011777012,"threshold_uncertainty_score":0.015662968},"labels":[],"label_agreement":null},{"id":"W4407780132","doi":"10.3390/biologics5010005","title":"Dupilumab for Chronic Obstructive Pulmonary Disease: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Biologics","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Pulmonary disease; Medicine; Intensive care medicine; COPD; Immunology; Internal medicine; Asthma","score_opus":0.04970187042711858,"score_gpt":0.37155866062248233,"score_spread":0.32185679019536373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407780132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006967698,0.9981882,0.0000903836,0.00019811942,0.000067336965,0.00034436348,0.00023143188,0.0000069674484,0.0001763787],"genre_scores_gemma":[0.012858592,0.98476934,0.00060363923,0.0004985784,0.00007534008,0.0008789658,0.00019651977,0.00000430993,0.00011473789],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99285346,0.0027946485,0.0022804786,0.0005207294,0.0013113815,0.00023929805],"domain_scores_gemma":[0.9796112,0.013333508,0.004517667,0.00027414458,0.0019551932,0.00030821844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076242727,0.0015685405,0.0085066855,0.008292826,0.0007242899,0.0022129694,0.0018064574,0.0018291676,0.0043311506],"category_scores_gemma":[0.029117832,0.0009253364,0.0069336058,0.008972552,0.000843471,0.0018821518,0.0014680394,0.0011500895,0.00033984016],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018319806,0.000011980812,0.00042639943,0.97041965,0.0074662385,0.00006663225,0.00011023088,0.00006015022,0.000097464406,0.000111722824,0.0011027241,0.019943628],"study_design_scores_gemma":[0.00044291877,0.0002945145,0.0034361656,0.88350743,0.094577126,0.00038237995,0.0002103588,0.000112432346,0.00015279239,0.00022920805,0.016615814,0.00003890163],"about_ca_topic_score_codex":0.008173684,"about_ca_topic_score_gemma":0.025890103,"teacher_disagreement_score":0.0085066855,"about_ca_system_score_codex":0.003984741,"about_ca_system_score_gemma":0.012283153,"threshold_uncertainty_score":0.04032147},"labels":[],"label_agreement":null},{"id":"W4413941335","doi":"10.3390/biologics5030026","title":"Cypress Pollen-Peach Cross-Reactivity: The Emerging Role of Pru p 7 as a Marker of Severe Allergic Phenotypes","year":2025,"lang":"en","type":"article","venue":"Biologics","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Cypress; Cross-reactivity; Pollen; Phenotype; Reactivity (psychology); Cross reactions; Biology; Botany; Medicine; Immunology; Genetics; Gene; Antigen; Pathology","score_opus":0.012917759381622112,"score_gpt":0.2886305791715239,"score_spread":0.2757128197899018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413941335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977325,0.001475465,0.00025492255,0.000047913734,0.0000074597074,0.000005573683,0.000044249115,0.000007972399,0.0004239426],"genre_scores_gemma":[0.9994848,0.00023555038,0.00013090152,0.00001832371,0.000022993472,0.0000019682961,0.000053420143,0.0000017523993,0.00005027661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995302,0.00013280522,0.00003977524,0.00012724484,0.00011089077,0.000059033267],"domain_scores_gemma":[0.99867505,0.00037027663,0.00058971316,0.000110636036,0.00011814143,0.00013626595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007079229,0.0003615337,0.0003879703,0.0010282922,0.00024311275,0.00052525353,0.00029352054,0.0004988553,0.0014136975],"category_scores_gemma":[0.0013200156,0.00013223526,0.00034056098,0.00066370494,0.0004216985,0.00035020683,0.00043159857,0.00043429193,0.0002188376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001768571,0.000024087902,0.98620266,0.000037941114,0.000042286872,0.0013344458,0.000096523865,0.00004134269,0.006355823,0.00003887696,0.00009462931,0.005554647],"study_design_scores_gemma":[0.00000305578,0.00016677202,0.989125,0.000012589469,0.000034205867,0.0090891365,0.00013106587,0.00026040588,0.0008149303,0.000044693094,0.0003143882,0.0000037363477],"about_ca_topic_score_codex":0.0004124292,"about_ca_topic_score_gemma":0.00029564774,"teacher_disagreement_score":0.0014136975,"about_ca_system_score_codex":0.00012002151,"about_ca_system_score_gemma":0.0001125582,"threshold_uncertainty_score":0.0047293305},"labels":[],"label_agreement":null},{"id":"W4414749562","doi":"10.2147/btt.s547672","title":"Migrasomes: A New Role in Disease Diagnosis and Treatment","year":2025,"lang":"en","type":"review","venue":"Biologics","topic":"Neuroscience of respiration and sleep","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Magna International (Canada)","funders":"","keywords":"Disease; Pathogenesis; Neuroinflammation; Organelle; Cell; Pathological; Signal transduction; Cell type","score_opus":0.13782832250217136,"score_gpt":0.36750087582606916,"score_spread":0.2296725533238978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414749562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005852668,0.99812514,0.00017049453,0.0006153423,0.00047421263,0.000002802481,0.000009095795,0.000008223042,0.00053601136],"genre_scores_gemma":[0.00059435976,0.997849,0.00020494865,0.00039360553,0.00051685877,0.0000063043185,0.00001814748,0.0000017013506,0.00041515185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997545,0.000055130964,0.000033093263,0.00004055337,0.000088357345,0.000028437535],"domain_scores_gemma":[0.9995565,0.0002287719,0.000040224513,0.000015404366,0.00010765429,0.000051416548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008834006,0.00093892356,0.001508626,0.0018914497,0.00032886193,0.0012828686,0.0009586863,0.0016752908,0.002663241],"category_scores_gemma":[0.0008806718,0.00022528763,0.0005630734,0.0010890404,0.00097331614,0.0018873313,0.0009776452,0.0033448138,0.0016260643],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106368156,0.00008408358,0.00018535799,0.011582467,0.00010190952,0.00029260633,0.00008801133,0.00033506125,0.0023283116,0.010771451,0.047129642,0.92699474],"study_design_scores_gemma":[0.000018057646,0.00010647051,0.00044225322,0.0024631878,0.000057761164,0.0010940409,0.000057798195,0.00009055799,0.00035200437,0.004846113,0.9904535,0.00001826176],"about_ca_topic_score_codex":0.00059527345,"about_ca_topic_score_gemma":0.0010997384,"teacher_disagreement_score":0.002663241,"about_ca_system_score_codex":0.0008762931,"about_ca_system_score_gemma":0.001185128,"threshold_uncertainty_score":0.008909464},"labels":[],"label_agreement":null}]}